PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $498,000 | +12.4% | 110,728 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $443,000 | -92.4% | 110,728 | -86.0% | 0.01% | -87.9% |
| Q1 2022 | $5,794,000 | -45.6% | 791,549 | -58.3% | 0.12% | +41.5% |
| Q4 2021 | $10,660,000 | +75.6% | 1,896,962 | +100.0% | 0.08% | -6.8% |
| Q3 2021 | $6,070,000 | -62.0% | 948,481 | -50.0% | 0.09% | -15.4% |
| Q2 2021 | $15,992,000 | -46.6% | 1,896,962 | -33.5% | 0.10% | -72.6% |
| Q1 2021 | $29,932,000 | -58.2% | 2,852,058 | -32.5% | 0.38% | -50.7% |
| Q4 2020 | $71,561,000 | +30.8% | 4,224,389 | -1.0% | 0.77% | -3.9% |
| Q3 2020 | $54,729,000 | -14.3% | 4,265,711 | -5.7% | 0.80% | -22.8% |
| Q2 2020 | $63,858,000 | +130.5% | 4,525,711 | +50.3% | 1.04% | +43.4% |
| Q1 2020 | $27,707,000 | -36.4% | 3,011,574 | +3.1% | 0.72% | -16.5% |
| Q4 2019 | $43,532,000 | +857.2% | 2,921,574 | +338.5% | 0.86% | +603.3% |
| Q3 2019 | $4,548,000 | – | 666,322 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |